Connor, Clark & Lunn Investment Management Ltd. Natera, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Natera, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 60,365 shares of NTRA stock, worth $9.39 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
60,365
Previous 72,128
16.31%
Holding current value
$9.39 Million
Previous $9.17 Million
4.23%
% of portfolio
0.05%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding NTRA
# of Institutions
635Shares Held
123MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$1.92 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.05 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.05 Billion0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$1.04 Billion0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$690 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.1B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...